Evaluating change in disease activity needed to reflect meaningful improvement in quality of life for clinical trials in cutaneous lupus erythematosus - 01/09/20
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Abstract |
Background |
Outcome measures of clinical trials in cutaneous lupus erythematosus (CLE) should reflect clinically meaningful improvement in disease activity, as measured by the Cutaneous Lupus Disease Area and Severity Index activity score (CLASI-A).
Objective |
We aimed to define the degree of improvement in disease activity meaningful to a patient's quality of life.
Methods |
The change in the CLASI-A in 126 patients needed to predict meaningful change in QoL, as defined by the Emotions and Symptoms subscales of the Skindex-29, was evaluated by linear regression models.
Results |
In patients with an initial CLASI-A of ≥8, a 42.1% or ≥7-point and a 31.0% or ≥5-point decrease in CLASI-A predicts meaningful improvement in the Emotions and the Symptoms subscales, respectively.
Limitations |
This is a retrospective study of prospectively collected data at a single site.
Conclusions |
A CLASI-A score of ≥8 for trial entry allows for inclusion of patients with milder disease where CLASI-A improvement by ≥50% is clinically significant and meaningful.
Le texte complet de cet article est disponible en PDF.Key words : autoimmune skin disease, clinical trials, cutaneous lupus erythematosus, efficacy measures, patient-reported outcomes, quality of life
Abbreviations used : CLASI, CLASI-A, CLE, DLQI, DM, QoL, Skindex-E, Skindex-F, Skindex-S, SLE
Plan
Funding sources: Supported by National Institutes of Health (K24-AR02207 and R01AR071653) and the U.S. Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development and Biomedical Laboratory Research and Development). |
|
Conflicts of interest: None disclosed. |
|
IRB approval status: N/A; IRB protocol #805758. |
|
Reprints not available from the authors. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?